Amplifon CEO Enrico Vita confronts antitrust challenges as his push for global hearing care consolidation draws regulatory attention. Competition authorities in multiple jurisdictions are monitoring moves toward vertical integration that would combine device manufacturing, retail distribution, and audiological services under single ownership.
The risk centers on market concentration. A "truly global vertically integrated" hearing care operator could control both supply chains and consumer access points, raising concerns about pricing power and competitor exclusion. Regulators may require asset divestitures in overlapping markets or block deals entirely.
Amplifon operates over 9,000 clinics across 26 countries, making it the world's largest hearing care retailer. Vita's consolidation strategy has driven dozens of acquisitions since he took the helm in 2018.
Vertical integration compounds regulatory scrutiny. If manufacturers also control retail distribution, independent audiologists lose access to competitive wholesale channels. Health regulators in the EU and US have blocked similar healthcare consolidations when vertical integration threatened to foreclose competition.
The likelihood of regulatory intervention increases with deal size and market overlap. Cross-border transactions face multiple review processes, each with authority to impose conditions or prohibit completion. Recent healthcare merger reviews in Europe have averaged 6-12 months, with remedy packages required in over 40% of approved deals.
Financial implications are substantial. Divesting clinics or distribution assets reduces synergy value and integration benefits. Blocked transactions waste deal costs and management focus while leaving market share gains to competitors. Private equity-backed hearing care consolidators continue acquiring assets, intensifying competitive pressure.
Amplifon must navigate this regulatory landscape while maintaining growth momentum. Vita's next moves will test whether global hearing care consolidation can clear antitrust hurdles or whether fragmentation persists across regional markets.
